Lv3
220 积分 2024-05-11 加入
Comparison of Managing Factor Xa Inhibitor to Unfractionated Heparin Transitions by aPTT Versus a Treatment Guideline Utilizing Heparin Anti-Xa Levels
5天前
已完结
Comparison of Managing Factor Xa Inhibitor to Unfractionated Heparin Transitions by aPTT Versus a Treatment Guideline Utilizing Heparin Anti-Xa Levels
10天前
已完结
Tirofiban potentiates agonist-induced platelet activation and degranulation, despite effectively inhibiting aggregation
11天前
已完结
Heparin and Low-Molecular-Weight Heparin
12天前
已完结
Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism
13天前
已完结
Comparing Anti–Factor Xa and Activated Partial Thromboplastin Levels for Monitoring Unfractionated Heparin
14天前
已完结
Activated Partial Thromboplastin Time Versus Antifactor Xa Heparin Assay in Monitoring Unfractionated Heparin by Continuous Intravenous Infusion
14天前
已完结
Monitoring Unfractionated Heparin Therapy with Antifactor Xa Activity Results in Fewer Monitoring Tests and Dosage Changes than Monitoring with the Activated Partial Thromboplastin Time
14天前
已完结
A Randomized Trial Comparing Activated Thromboplastin Time With Heparin Assay in Patients With Acute Venous Thromboembolism Requiring Large Daily Doses of Heparin
14天前
已完结
High Factor VIII Levels Independently Predict Venous Thromboembolism in Cancer Patients
14天前
已完结
皖公网安备34019202002308
